CIK: 1279191 - Address: 3525 Del Mar Heights Rd., #322, San Diego, CA 92130
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret4163312-1225115
P%wins67678333404055

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/26/21 13:30
11/23/21
DRMADermata Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsProehl Gerald TCADOTP,CEO,CBP482.4002013,180D
8/17/21 12:38
8/16/21
DRMADermata Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsProehl Gerald TCADOTP,CEO,CBP.dm500.3247015353,160I
11/29/16 15:55
11/22/16
TENXTenax Therapeutics, Inc.DEHealthBiolabCommercial Physical & BiologiProehl Gerald TNCDP.m501.67030New30D-53-45-32-25-10292856119-59
6/25/15 20:58
6/24/15
RTTRRitter Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsProehl Gerald TCADP2505.00450New50D-2-4-13-37-57-62
9/22/14 18:58
9/19/14
ASPXAuspex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsProehl Gerald TCADP3221.7501New1D
9/19/14 16:19
9/19/14
SPHSSophiris Bio Inc.A1HealthDrugPharmaceutical PreparationsProehl Gerald TCADP323.16010New10D-84-37-1241191-3-6440-76-74-59
3/16/09 16:59
3/16/09
SNTSSantarus IncDEHealthDrugPharmaceutical PreparationsProehl Gerald TCADOP,CEOP491.2204024205583995151280
12/12/07 16:43
12/11/07
SNTSSantarus IncDEHealthDrugPharmaceutical PreparationsProehl Gerald TCADOP,CEOP682.721253792D-55-68-49-220102-2-2-70-10-23-24
5/31/05 19:55
5/31/05
SNTSSantarus IncDEHealthDrugPharmaceutical PreparationsProehl Gerald TCADOP,CEOP313.111106178D-79-69-57-35-25-8-8453781111122

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact